<i>Okadaella gastrococcus </i>and cancer

摘要

The present invention provides compositions, methods of manufacture, process and uses for diagnosing, preventing, inhibiting, and treating the development and proliferation of diseases and disorders associated with Okadaella gastrococcus (Og) bacterial infection in a patient.

主权项

1. A method of treatment of a human subject suffering from adenocarcinoma or lymphoma associated with an Okadaella gastrococcus infection in the absence of an Helicobacter pylori infection, said method comprising administering to the subject:
a first plurality of antibiotics comprising at least ampicillin or amoxicillin and one or more of a tetracycline, a quinolone, and rifampicin, and at least one proton pump inhibitor selected from the group consisting of omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole and zegarid in combination for two weeks, and then administering to the subject a second plurality of antibiotics comprising at least ampicillin or amoxicillin and one or more of a tetracycline, a quinolone, and rifampicin, and at least one proton pump inhibitor selected from the group consisting of omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole and zegarid in combination for four weeks, wherein the administering is sufficient to reduce and/or eradicate the presence of Okadaella gastrococcus in the subject.